...
phvs-img

Pharvaris BV, Common Stock

PHVS

NSQ

$21.5

+$0.68

(3.27%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.12B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
138.70K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-3.10
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$15 L
$33 H
$21.5

About Pharvaris BV, Common Stock

Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks which is under Phase 2 clinical trial; and PHVS719, a prophylactic extended-release tablet for HAE patients which is under Phase 1 clinical trial. The company operates in the Netherlands, Switzerland, and the United States. Pharvaris N.V. was incorporated in 2015 and is based in Leiden, the Netherlands. more

Industry: BiotechnologySector: Health Care

Returns

Time FramePHVSSectorS&P500
1-Week Return20.04%-0.32%0.48%
1-Month Return4.37%-2.79%3.02%
3-Month Return16.03%2%2.69%
6-Month Return2.38%10.22%15.17%
1-Year Return10.82%16.53%33.06%
3-Year Return37.02%20.26%29.62%
5-Year Return-25.86%67.2%94.46%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue547.41-80.46K150.19K252.27K[{"date":"2019-12-31","value":0.22,"profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":31.89,"profit":true},{"date":"2022-12-31","value":59.53,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(547.41)-(80.46K)(150.19K)(252.27K)[{"date":"2019-12-31","value":-54741,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-8045600,"profit":false},{"date":"2022-12-31","value":-15018600,"profit":false},{"date":"2023-12-31","value":-25227100,"profit":false}]
Gross Margin(Infinity%)-(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":null,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses8.01M25.01M54.14M86.71M96.91M[{"date":"2019-12-31","value":8.27,"profit":true},{"date":"2020-12-31","value":25.8,"profit":true},{"date":"2021-12-31","value":55.86,"profit":true},{"date":"2022-12-31","value":89.48,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(7.99M)(25.01M)(65.90M)(86.74M)(96.91M)[{"date":"2019-12-31","value":-799340000,"profit":false},{"date":"2020-12-31","value":-2501280000,"profit":false},{"date":"2021-12-31","value":-6589909500,"profit":false},{"date":"2022-12-31","value":-8673775700,"profit":false},{"date":"2023-12-31","value":-9691362000,"profit":false}]
Total Non-Operating Income/Expense-(1.15M)22.96M11.05M(2.70M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-5.03,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":48.11,"profit":true},{"date":"2023-12-31","value":-11.76,"profit":false}]
Pre-Tax Income(8.03M)(26.07M)(42.66M)(75.65M)(99.83M)[{"date":"2019-12-31","value":-802716200,"profit":false},{"date":"2020-12-31","value":-2606895500,"profit":false},{"date":"2021-12-31","value":-4266066200,"profit":false},{"date":"2022-12-31","value":-7565347000,"profit":false},{"date":"2023-12-31","value":-9982626200,"profit":false}]
Income Taxes16.88K(83.25K)70.12K679.09K1.05M[{"date":"2019-12-31","value":1.61,"profit":true},{"date":"2020-12-31","value":-7.94,"profit":false},{"date":"2021-12-31","value":6.69,"profit":true},{"date":"2022-12-31","value":64.75,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes-(25.99M)(42.73M)(76.33M)(100.88M)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-2598570400,"profit":false},{"date":"2021-12-31","value":-4273077900,"profit":false},{"date":"2022-12-31","value":-7633255700,"profit":false},{"date":"2023-12-31","value":-10087506700,"profit":false}]
Income From Continuous Operations(8.03M)(25.99M)(42.73M)(76.33M)(107.32M)[{"date":"2019-12-31","value":-802716200,"profit":false},{"date":"2020-12-31","value":-2598570400,"profit":false},{"date":"2021-12-31","value":-4273077900,"profit":false},{"date":"2022-12-31","value":-7633255700,"profit":false},{"date":"2023-12-31","value":-10732407300,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(8.04M)(25.99M)(42.73M)(76.33M)(100.88M)[{"date":"2019-12-31","value":-804404300,"profit":false},{"date":"2020-12-31","value":-2598570400,"profit":false},{"date":"2021-12-31","value":-4273077900,"profit":false},{"date":"2022-12-31","value":-7633255700,"profit":false},{"date":"2023-12-31","value":-10087500000,"profit":false}]
EPS (Diluted)-(3.45)(3.60)(2.36)(3.20)[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-344.99,"profit":false},{"date":"2021-12-31","value":-360,"profit":false},{"date":"2022-12-31","value":-236,"profit":false},{"date":"2023-12-31","value":-320,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PHVS
Cash Ratio 18.05
Current Ratio 18.45
Quick Ratio 18.45

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PHVS
ROA (LTM) -26.79%
ROE (LTM) -45.05%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PHVS
Debt Ratio Lower is generally better. Negative is bad. 0.05
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.95

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PHVS
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 3.04
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Pharvaris BV share price today?

Pharvaris BV (PHVS) share price today is $21.5

Can Indians buy Pharvaris BV shares?

Yes, Indians can buy shares of Pharvaris BV (PHVS) on Vested. To buy Pharvaris BV from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PHVS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Pharvaris BV be purchased?

Yes, you can purchase fractional shares of Pharvaris BV (PHVS) via the Vested app. You can start investing in Pharvaris BV (PHVS) with a minimum investment of $1.

How to invest in Pharvaris BV shares from India?

You can invest in shares of Pharvaris BV (PHVS) via Vested in three simple steps:

  • Click on Sign Up or Invest in PHVS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Pharvaris BV shares
What is Pharvaris BV 52-week high and low stock price?

The 52-week high price of Pharvaris BV (PHVS) is $33. The 52-week low price of Pharvaris BV (PHVS) is $15.

What is Pharvaris BV price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Pharvaris BV (PHVS) is

What is Pharvaris BV price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Pharvaris BV (PHVS) is 3.04

What is Pharvaris BV dividend yield?

The dividend yield of Pharvaris BV (PHVS) is 0.00%

What is the Market Cap of Pharvaris BV?

The market capitalization of Pharvaris BV (PHVS) is $1.12B

What is Pharvaris BV’s stock symbol?

The stock symbol (or ticker) of Pharvaris BV is PHVS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top